Clinical Trials in Baltimore

Showing 10321-10340 of 23,476 trials

Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to Apixaban

NCT04895553

Glioma patients with history of venous thromboembolism (VTE) treated on low molecular weight heparin (LMWH) and who decided with their physician to convert to Apixaban (oral drug) will be enrolled into our study and will collect data regarding recurrent VTE and Intracranial hemorrhage and the incidence of these events.

Glioma, Malignant

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins60 participantsStarted Aug 2021

Sacramento, California, United States • Baltimore, Maryland, United States

COMPLETEDNA< 1 mile

Peer-Delivered Behavioral Activation for Methadone Adherence - Pilot Phase

NCT04248933

The purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) among low-income, minoritized individuals living with opioid use disorder (OUD) in Baltimore, Maryland. The intervention is based on behavioral activation (BA) and is specifically designed to be implemented by a trained peer recovery specialist. In this pilot trial, the investigators will evaluate the feasibility, acceptability, and fidelity of this approach (implementation outcomes) and preliminary effectiveness on methadone treatment retention at three months.

Substance UseSubstance Use DisordersOpioid-use Disorder+5 more

University of Maryland, College Park37 participantsStarted Oct 2020

Baltimore, Maryland, United States • College Park, Maryland, United States

Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to Apixaban

Peer-Delivered Behavioral Activation for Methadone Adherence - Pilot Phase

Find Trials by Condition in Baltimore

Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease

A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma

Project 1, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Childbearing Age Women

Project 2, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Opioid Abusers

Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients

Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease

An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women

Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-T

Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer

SMART Optimization of a Parenting Program for Active-duty Families

Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis

A Post-market Study Of Use Of The OMNI® Surgical System In Open Angle Glaucoma

Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen

A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions

A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.

A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age